Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
British Journal of Cancer|September 6, 2017
Anti-Mullerian hormone and endometrial cancer: a multi-cohort studyRenée T Fortner, Helena Schock, Seungyoun Jung, et al.Fertility and Sterility|April 4, 2017
Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal womenSeungyoun Jung, Naomi Allen, Alan A Arslan, et al.International Journal of Cancer|September 19, 2017
Anti-Müllerian hormone and risk of ovarian cancer in nine cohortsSeungyoun Jung, Naomi Allen, Alan A Arslan, et al.BMC Cancer|October 24, 2018
Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohortDanja Sarink, Helena Schock, Theron Johnson, et al.Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2017
Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC CohortDanja Sarink, Helena Schock, Theron Johnson, et al.European Journal of Epidemiology|May 14, 2015
An epidemiological model for prediction of endometrial cancer risk in EuropeAnika Hüsing, Laure Dossus, Pietro Ferrari, et al.BMC Medicine|February 9, 2017
Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohortRenée T Fortner, Danja Sarink, Helena Schock, et al.International Journal of Cancer|October 25, 2013
Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohortRudolf Kaaks, Kaja Tikk, Disorn Sookthai, et al.International Journal of Cancer|June 4, 2014
Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and NutritionJennifer Ose, Renée T Fortner, Sabina Rinaldi, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2015
Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC CohortJennifer Ose, Helena Schock, Anne Tjønneland, et al.Pageof 4